-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

102.O1.6 102. Regulation of Iron Metabolism: Hepcidin and the Regulation of Iron Homeostasis Clinically Relevant Abstract

Regulation of Iron Metabolism Program: Oral and Poster Abstracts
Type: Oral
Sunday, December 4, 2016: 7:30 AM-9:15 AM
Grand Hall A (Manchester Grand Hyatt San Diego)
Moderators:
Barry H. Paw, M.D., Ph.D., Brigham and Women's Hospital, Harvard Medical School and Thomas Benedict Bartnikas, MD PhD, Brown University
Disclosures:
No relevant conflicts of interest to declare.
7:30 AM

Roberta Chessa, PhD1*, Ritama Gupta, MSc2*, Carla Casu, PhD2*, Robert E Fleming, MD3,4, Yelena Ginzburg5*, Brian MacDonald, MB, ChB, PhD6* and Stefano Rivella, PhD2

1Hematology, Children Hospital of Philadelphia, Philadelphia, PA
2Children's Hospital of Philadelphia, Philadelphia, PA
3Edward A. Doisy Department of Biochemistry and Molecular Biology, Saint Louis University, St. Louis, MO
4Pediatrics, Saint Louis University School of Medicine, St. Louis, MO
5Icahn School of Medicine at Mount Sinai, New York
6Merganser Biotech inc, King of Prussia, PA

7:45 AM

Deborah Stefanova1*, Joao Arezes, PhD2*, Kathryn Michels3*, Barbara Dillon1*, Marcus Horwitz1*, Borna Mehrad3*, Yonca Bulut1*, Tomas Ganz, MD, PhD1 and Elizabeta Nemeth, PhD1

1UCLA Center for Iron Disorders, Los Angeles, CA
2University of Oxford, Oxford, United Kingdom
3University of Virginia, Charlottesville, VA

8:00 AM

Laura Silvestri, PhD1,2, Silvia Colucci1*, Alessia Pagani, PhD1*, Irene Artuso, BSc2*, Mariatesera Pettinato, BSc2*, Antonella Nai, PhD1,2 and Clara Camaschella, MD1,2

1Vita Salute San Raffaele University, Milan, Italy
2Division of Genetics and Cell Biology, IRCCS San Raffaele Scientific Institute, Milan, Italy

8:15 AM

Celine Besson-Fournier1*, Aurelie Gineste1*, Chloe Latour1*, Ophelie Gourbeyre1*, Delphine Meynard, PhD1*, Patricia Aguilar-Martinez, MD, PhD2, Eric Oswald, DVM, PhD1*, Patricia Martin, PhD1*, Helene Coppin, PhD1* and Marie-Paule Roth, MD1*

1IRSD, Inserm U1220, Toulouse, France
2Laboratory of Hematology, University Hospital Montpellier, Montpellier, France

8:30 AM

Peter Peterson, PhD*, Wontak Kim*, Hillary Haws*, Clifford J. Whatcott, PhD*, Adam Siddiqui-Jain, PhD*, David J. Bearss, PhD and Steven L. Warner, PhD

Tolero Pharmaceuticals, Inc., Lehi, UT

8:45 AM

Chiara Piubelli, PhD1,2*, Annalisa Castagna, PhD1,2*, Giacomo Marchi, MD1,2*, Monica Rizzi, MD1,2*, Fabiana Busti, MD1,2*, Monia Marchetti, MD, PhD3*, Marco De Gobbi, MD, PhD4*, Antonella Roetto, PhD, BSc5*, Luciano Xumerle6*, Alejandro Giorgetti, PhD6*, Massimo Delledonne, PhD6*, Oliviero Olivieri, MD1,2* and Domenico Girelli, MD, PhD1,2

1Department of Medicine, University of Verona, Verona, Italy
2Veneto Region Referral Centre for Iron Disorders, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy
3Oncology Unit, Ospedale Cardinal Massaia, ASTI, Italy
4Department of Clinical and Biological Sciences, University of Turin, Orbassano (TO), Italy
5Dept. Of Clinical and Biological Sciences, University of Turin, Orbassano (TO), Italy
6Department of Biotechnology, University of Verona, Verona, Italy

9:00 AM

Yvette Y Yien, PhD1, Gael Nicolas, PhD2*, Lisa van der Vorm1*, Laurent Gouya, MD, PhD2*, Hector Begonia3*, Martin Kafina1*, Jean-Charles Deybach, MD, PhD2*, Tania Baker, PhD4*, Julia Kardon, PhD4*, John D. Phillips, PhD3, Hervé Puy, MD, PhD2* and Barry H. Paw, M.D., Ph.D.1

1Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
2INSERM, Universite Paris, Paris, France, Paris, France
3Medicine/Hematology, University of Utah School of Medicine, Salt Lake City, UT
4Department of Biology, Massachusetts Institute of Technology, Boston, MA

*signifies non-member of ASH